Smoking and mental health - NCSCT

Neurobiological and behavioural mechanisms linking smoking and mental disorders 3
> The association between smoking and mental disorders is therefore complex
and further work is needed to help improve understanding.
References
1 Corrigall WA, Coen KM. Nicotine maintains robust self-administration in rats on a
limited-access schedule. Psychopharmacology 1989;99:473–8.
2 Donny EC, Caggiula AR, Knopf S, Brown C. Nicotine self-administration in rats.
Psychopharmacology 1995;122:390–94.
3 Epping-Jordan MP, Watkins SS, Koob GF, Markou A. Dramatic decreases in brain reward
function during nicotine withdrawal. Nature 1998;393:76–9.
4 Malin DH, Lake JR, Newlin-Maultsby P, et al. Rodent model of nicotine abstinence
syndrome. Pharmacology, Biochemistry and Behavior 1992;43:779–84.
5 Kenny PJ, Markou A. Neurobiology of the nicotine withdrawal syndrome. Pharmacology,
Biochemistry and Behavior 2001;70:531–49.
6 Malin DH, Goyarzu P. Rodent models of nicotine withdrawal syndrome. Handbook of
Experimental Pharmacology 2009;192:401–34.
7 Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction.
European Journal of Pharmacology 2000;393:295–314.
8 Di Chiara G, Bassareo V, Fenu S, et al. Dopamine and drug addiction: the nucleus
accumbens shell connection. Neuropharmacology 2004;47(suppl 1):227–41.
9 Lecca D, Cacciapaglia F, Valentini V, et al. Preferential increase of extracellular dopamine
in the rat nucleus accumbens shell as compared to that in the core during acquisition and
maintenance of intravenous nicotine self-administration. Psychopharmacology
2006;184:435–46.
10 Benwell ME, Balfour DJ. The effects of acute and repeated nicotine treatment on nucleus
accumbens dopamine and locomotor activity. British Journal of Pharmacology
1992;105:849–56.
11 Cadoni C, Di Chiara G. Differential changes in accumbens shell and core dopamine in
behavioral sensitization to nicotine. European Journal of Pharmacology 2000;387:R23–5.
12 Iyaniwura TT, Wright AE, Balfour DJ. Evidence that mesoaccumbens dopamine and
locomotor responses to nicotine in the rat are influenced by pretreatment dose and strain.
Psychopharmacology 2001;158:73–9.
13 Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in
compulsive drug use. Journal of Psychopharmacology 1998;12:54–67.
14 Di Chiara G, Bassareo V. Reward system and addiction: what dopamine does and doesn’t
do. Current Opinion in Pharmacology 2007;7:69–76.
15 Balfour DJ. The neuronal pathways mediating the behavioral and addictive properties of
nicotine. Handbook of Experimental Pharmacology 2009;192:209–33.
16 Fowler JS, Logan J, Wang GJ, Volkow ND. Monoamine oxidase and cigarette smoking.
Neurotoxicology 2003;24:75–82.
17 Fowler JS, Volkow ND, Wang GJ, et al. Inhibition of monoamine oxidase B in the brains of
smokers. Nature 1996;379:733–6.
18 Fowler JS, Volkow ND, Wang GJ, et al. Brain monoamine oxidase A inhibition in cigarette
smokers. Proceedings of the National Academy of Sciences of the USA 1996;93:14065–9.
19 Guillem K, Vouillac C, Azar MR, et al. Monoamine oxidase inhibition dramatically
increases the motivation to self-administer nicotine in rats. Journal of Neuroscience
2005;25:8593–600.
© Royal College of Physicians 2013 53